Rodrigo Cézar

Rodrigo Cézar has a diverse range of work experience, with their most recent position being the Director of Country Operations at Indivumed Group. In this role, they are responsible for establishing and expanding the clinical network and infrastructure for the collection and management of biosamples for the cancer global multiomics database, lndivuType. Rodrigo oversees the implementation and management of clinical operations, ensuring compliance with ethical and regulatory processes.

Prior to their current role, Rodrigo worked as a Senior Key Account Manager at Grupo Fleury, where they were responsible for sales and medical relationships in the fields of Oncology, Hematology, Neurology, and Rare Diseases genetic tests. Rodrigo conducted demand analysis and market intelligence studies in these specialties and had extensive knowledge of the genomic market in Brazil.

Rodrigo also has experience in laboratory management, having served as the Lab Outsourcing Manager and Head of Molecular Biology and Flow Cytometry Labs at Hospital São Rafael. Rodrigo implemented the laboratory protocol for the CAR-T cell program and was responsible for the entire process from pre-analytical to post-analytical stages.

In addition to their industry experience, Rodrigo has held teaching positions as an Associate Professor at Faculdade UNIME, Professor of Hematology at Faculdade Dom Pedro II - Grupo UNIDOM and UNIRB - Faculdade Regional da Bahia, and Assistant Professor at Universidade Federal da Bahia.

Rodrigo's career began in the Marinha do Brasil, where they served as a First-Lieutenant Pharmacist, Medical Laboratory Scientist, and Laboratory Manager. Rodrigo managed the hospital pharmacy, was responsible for technical matters, bids, and contracts, and had expertise in hematology, clinical chemistry, immunology, toxicology, and microbiology.

Overall, Rodrigo Cézar has a strong background in clinical operations, sales and marketing, laboratory management, and teaching.

Rodrigo Cézar has an extensive education history. In 1997, they completed their Doctor of Pharmacy (PharmD) degree at Universidade Federal da Bahia, specializing in Pharmacy. Following this, from 2003 to 2004, Rodrigo pursued a Postgraduate Degree in Onco-hematology at the same institution. Rodrigo continued their education and obtained a Master's degree in Molecular Biology / Hematology from Universidade Federal da Bahia, which they completed from 2010 to 2012. Rodrigo then pursued a Doctor of Philosophy (PhD) in Pathology/Experimental Pathology at Universidade Federal da Bahia starting in 2013.

In 2018, Rodrigo enrolled in a Graduate course in Business Administration and Management, General at Fundação Dom Cabral. Rodrigo completed this program in 2022.

In addition to their academic degrees, Rodrigo has obtained several certifications. These include "ACCESS TO MEDICINES ON THE PUBLIC AND PRIVATE MARKETS" from INAFF - National Institute of Pharmaceutical Care and Pharmacoeconomics in October 2022, "Leader Coach: leading to high performance" from SEBRAE in August 2021, and "Executive Certification: Business Development, Leadership and Networking" from FIA ONLINE in July 2021. Other certifications include "INTRODUCTION TO GOOD CLINICAL LABORATORY PRACTICE," "DATA SAFETY AND MONITORING BOARDS FOR CLINICAL TRIALS," "INTRODUCTION TO CLINICAL RESEARCH," and "INTRODUCTION TO COLLECTING AND REPORTING ADVERSE EVENTS IN CLINICAL RESEARCH" from The Global Health Network, all obtained in 2021. Rodrigo also obtained certifications in "Marketing Fundamentals" and "Sales Management: Basics of Strategy Creation" from Fundação Getulio Vargas in February 2021, and "Good Clinical Practices" from The National Institute on Drug Abuse (NIDA) in May 2021.

It is important to note that Rodrigo has also pursued a Laboratory Specialist Title in Hematology from the Associacao Brasileira De Hematologia E Hemoterapia (ABHH), but the specific completion date and month are not provided.